<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">38400172</PMID><DateRevised><Year>2024</Year><Month>02</Month><Day>27</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Print">2076-393X</ISSN><JournalIssue CitedMedium="Print"><Volume>12</Volume><Issue>2</Issue><PubDate><Year>2024</Year><Month>Feb</Month><Day>12</Day></PubDate></JournalIssue><Title>Vaccines</Title><ISOAbbreviation>Vaccines (Basel)</ISOAbbreviation></Journal><ArticleTitle>Impact of Pre-Infection COVID-19 Vaccination on the Incidence and Severity of Post-COVID Syndrome: A Systematic Review and Meta-Analysis.</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">189</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3390/vaccines12020189</ELocationID><Abstract><AbstractText>This systematic review critically evaluated the impact of a pre-infection COVID-19 vaccination on the incidence and severity of post-COVID-19 syndrome and aimed to assess the potential protective effect across different vaccines and patient demographics. This study hypothesized that vaccination before infection substantially reduces the risk and severity of post-COVID-19 syndrome. In October 2023, a comprehensive literature search was conducted across three databases, PubMed, Embase, and Scopus, focusing on studies published up to that date. Utilizing a wide array of keywords, the search strategy adhered to the PRISMA guidelines and was registered in the Open Science Framework. The inclusion criteria comprised studies focusing on patients with a breakthrough SARS-CoV-2 infection who developed post-COVID-19 syndrome. We included a total of 13 articles that met the inclusion criteria, analyzing more than 10 million patients with a mean age of 50.6 years, showing that the incidence of intensive care unit (ICU) admissions post-vaccination was as low as 2.4%, with a significant reduction in mortality risk (OR 0.66, 95% CI 0.58-0.74). The prevalence of post-COVID-19 syndrome symptoms was lower in vaccinated individuals (9.5%) compared to unvaccinated (14.6%), with a notable decrease in activity-limiting symptoms (adjusted OR 0.59, 95% CI 0.48-0.73). Vaccinated patients also showed a quicker recovery and return to work (HR 1.37, 95% CI 1.04-1.79). The pooled odds ratio of 0.77 indicates that vaccination is associated with a 23% reduction in the risk of developing post-COVID-19 syndrome (95% CI 0.75-0.79). Despite the protective effects observed, a substantial heterogeneity among the studies was noted. In conclusion, a pre-infection COVID-19 vaccination is associated with a significant reduction in the risk and severity of post-COVID-19 syndrome. However, the observed heterogeneity across studies suggests a need for further research with standardized methods to fully comprehend vaccine efficacy against long COVID.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Man</LastName><ForeName>Milena Adina</ForeName><Initials>MA</Initials><AffiliationInfo><Affiliation>Department of Medical Sciences-Pulmonology, University of Medicine and Pharmacy, "Iuliu Hatieganu", 400012 Cluj Napoca, Romania.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rosca</LastName><ForeName>Daniela</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Doctoral School, "Victor Babes" University of Medicine and Pharmacy Timisoara, 300041 Timisoara, Romania.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bratosin</LastName><ForeName>Felix</ForeName><Initials>F</Initials><Identifier Source="ORCID">0000-0003-4711-4315</Identifier><AffiliationInfo><Affiliation>Doctoral School, "Victor Babes" University of Medicine and Pharmacy Timisoara, 300041 Timisoara, Romania.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Discipline of Infectious Diseases, "Victor Babes" University of Medicine and Pharmacy Timisoara, 300041 Timisoara, Romania.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Fira-Mladinescu</LastName><ForeName>Ovidiu</ForeName><Initials>O</Initials><Identifier Source="ORCID">0000-0002-9034-5218</Identifier><AffiliationInfo><Affiliation>Center for Research and Innovation in Precision Medicine of Respiratory Diseases, "Victor Babes" University of Medicine and Pharmacy Timisoara, 300041 Timisoara, Romania.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Discipline of Pulmonology, "Victor Babes" University of Medicine and Pharmacy Timisoara, 300041 Timisoara, Romania.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ilie</LastName><ForeName>Adrian Cosmin</ForeName><Initials>AC</Initials><AffiliationInfo><Affiliation>Department III Functional Sciences, Division of Public Health and Management, "Victor Babes" University of Medicine and Pharmacy Timisoara, 300041 Timisoara, Romania.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Burtic</LastName><ForeName>Sonia-Roxana</ForeName><Initials>SR</Initials><AffiliationInfo><Affiliation>Doctoral School, "Victor Babes" University of Medicine and Pharmacy Timisoara, 300041 Timisoara, Romania.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department II, Discipline of Medical Communication, "Victor Babes" University of Medicine and Pharmacy, 300041 Timisoara, Romania.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Fildan</LastName><ForeName>Ariadna Petronela</ForeName><Initials>AP</Initials><AffiliationInfo><Affiliation>Department of Pulmonology, Faculty of Medicine, "Ovidius" University of Constanta, 900470 Constanta, Romania.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Fizedean</LastName><ForeName>Camelia Melania</ForeName><Initials>CM</Initials><Identifier Source="ORCID">0000-0003-2242-5301</Identifier><AffiliationInfo><Affiliation>Methodological and Infectious Diseases Research Center, Department of Infectious Diseases, "Victor Babes" University of Medicine and Pharmacy, 300041 Timisoara, Romania.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Jianu</LastName><ForeName>Adelina Maria</ForeName><Initials>AM</Initials><AffiliationInfo><Affiliation>Department of Anatomy and Embriology, "Victor Babes" University of Medicine and Pharmacy, 300041 Timisoara, Romania.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Negrean</LastName><ForeName>Rodica Anamaria</ForeName><Initials>RA</Initials><AffiliationInfo><Affiliation>Department of Physiology, Faculty of Medicine and Pharmacy, University of Oradea, 410073 Oradea, Romania.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Marc</LastName><ForeName>Monica Steluta</ForeName><Initials>MS</Initials><Identifier Source="ORCID">0000-0003-1160-9164</Identifier><AffiliationInfo><Affiliation>Center for Research and Innovation in Precision Medicine of Respiratory Diseases, "Victor Babes" University of Medicine and Pharmacy Timisoara, 300041 Timisoara, Romania.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Discipline of Pulmonology, "Victor Babes" University of Medicine and Pharmacy Timisoara, 300041 Timisoara, Romania.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016454">Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>02</Month><Day>12</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Vaccines (Basel)</MedlineTA><NlmUniqueID>101629355</NlmUniqueID><ISSNLinking>2076-393X</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">COVID-19</Keyword><Keyword MajorTopicYN="N">SARS-CoV-2</Keyword><Keyword MajorTopicYN="N">coronavirus</Keyword><Keyword MajorTopicYN="N">infection</Keyword><Keyword MajorTopicYN="N">long-COVID</Keyword><Keyword MajorTopicYN="N">post-COVID-19 syndrome</Keyword><Keyword MajorTopicYN="N">vaccination</Keyword></KeywordList><CoiStatement>The authors declare no conflict of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2023</Year><Month>12</Month><Day>7</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2024</Year><Month>1</Month><Day>25</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>2</Month><Day>10</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>2</Month><Day>24</Day><Hour>11</Hour><Minute>45</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>2</Month><Day>24</Day><Hour>11</Hour><Minute>44</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>2</Month><Day>24</Day><Hour>1</Hour><Minute>23</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>2</Month><Day>12</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">38400172</ArticleId><ArticleId IdType="pmc">PMC10893048</ArticleId><ArticleId IdType="doi">10.3390/vaccines12020189</ArticleId><ArticleId IdType="pii">vaccines12020189</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Sawicka B., Aslan I., Della Corte V., Periasamy A., Krishnamurthy S.K., Mohammed A., Tolba Said M.M., Saravanan P., Del Gaudio G., Adom D., et al. The coronavirus global pandemic and its impacts on society. Coronavirus Drug Discov. 2022;1:267&#x2013;311. doi: 10.1016/B978-0-323-85156-5.00037-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/B978-0-323-85156-5.00037-7</ArticleId></ArticleIdList></Reference><Reference><Citation>Feier C.V.I., Bardan R., Muntean C., Olariu A., Olariu S. Impact of the COVID-19 Pandemic on the Elective Surgery for Colorectal Cancer: Lessons to Be Learned. Medicina. 2022;58:1322. doi: 10.3390/medicina58101322.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/medicina58101322</ArticleId><ArticleId IdType="pmc">PMC9609708</ArticleId><ArticleId IdType="pubmed">36295483</ArticleId></ArticleIdList></Reference><Reference><Citation>Haileamlak A. The impact of COVID-19 on health and health systems. Ethiop. J. Health Sci. 2021;31:1073&#x2013;1074.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8968362</ArticleId><ArticleId IdType="pubmed">35392335</ArticleId></ArticleIdList></Reference><Reference><Citation>Toma A.-O., Prodan M., Reddyreddy A.R., Seclaman E., Crainiceanu Z., Bloanca V., Bratosin F., Dumitru C., Pilut C.N., Alambaram S., et al. The Epidemiology of Malignant Melanoma during the First Two Years of the COVID-19 Pandemic: A Systematic Review. Int. J. Environ. Res. Public Health. 2022;20:305. doi: 10.3390/ijerph20010305.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijerph20010305</ArticleId><ArticleId IdType="pmc">PMC9819675</ArticleId><ArticleId IdType="pubmed">36612627</ArticleId></ArticleIdList></Reference><Reference><Citation>Fericean R.M., Rosca O., Citu C., Manolescu D., Bloanca V., Toma A.-O., Boeriu E., Dumitru C., Ravulapalli M., Barbos V., et al. COVID-19 Clinical Features and Outcomes in Elderly Patients during Six Pandemic Waves. J. Clin. Med. 2022;11:6803. doi: 10.3390/jcm11226803.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/jcm11226803</ArticleId><ArticleId IdType="pmc">PMC9692444</ArticleId><ArticleId IdType="pubmed">36431282</ArticleId></ArticleIdList></Reference><Reference><Citation>Allan M., Li&#xe8;vre M., Laurenson-Schaefer H., de Barros S., Jinnai Y., Andrews S., Stricker T., Formigo J.P., Schultz C., Perrocheau A., et al. The World Health Organization COVID-19 surveillance database. Int. J. Equity Health. 2022;21:1&#x2013;16. doi: 10.1186/s12939-022-01767-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12939-022-01767-5</ArticleId><ArticleId IdType="pmc">PMC9685131</ArticleId><ArticleId IdType="pubmed">36419127</ArticleId></ArticleIdList></Reference><Reference><Citation>Rahman M., Masum H.U., Wajed S., Talukder A. A comprehensive review on COVID-19 vaccines: Development, effectiveness, adverse effects, distribution and challenges. VirusDisease. 2022;33:1&#x2013;22. doi: 10.1007/s13337-022-00755-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s13337-022-00755-1</ArticleId><ArticleId IdType="pmc">PMC8806010</ArticleId><ArticleId IdType="pubmed">35127995</ArticleId></ArticleIdList></Reference><Reference><Citation>Chirico F., da Silva J.T., Tsigaris P., Sharun K. Safety &amp; effectiveness of COVID-19 vaccines: A narrative review. Indian J. Med Res. 2022;155:91&#x2013;104. doi: 10.4103/ijmr.ijmr_474_21.</Citation><ArticleIdList><ArticleId IdType="doi">10.4103/ijmr.ijmr_474_21</ArticleId><ArticleId IdType="pmc">PMC9552389</ArticleId><ArticleId IdType="pubmed">35859436</ArticleId></ArticleIdList></Reference><Reference><Citation>Rahmani K., Shavaleh R., Forouhi M., Disfani H.F., Kamandi M., Oskooi R.K., Foogerdi M., Soltani M., Rahchamani M., Mohaddespour M., et al. The effectiveness of COVID-19 vaccines in reducing the incidence, hospitalization, and mortality from COVID-19: A systematic review and meta-analysis. Front. Public Health. 2022;10:873596. doi: 10.3389/fpubh.2022.873596.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fpubh.2022.873596</ArticleId><ArticleId IdType="pmc">PMC9459165</ArticleId><ArticleId IdType="pubmed">36091533</ArticleId></ArticleIdList></Reference><Reference><Citation>Mohammed I., Nauman A., Paul P., Ganesan S., Chen K.-H., Jalil S.M.S., Jaouni S.H., Kawas H., Khan W.A., Vattoth A.L., et al. The efficacy and effectiveness of the COVID-19 vaccines in reducing infection, severity, hospitalization, and mortality: A systematic review. Hum. Vaccines Immunother. 2022;18:2027160. doi: 10.1080/21645515.2022.2027160.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/21645515.2022.2027160</ArticleId><ArticleId IdType="pmc">PMC8862168</ArticleId><ArticleId IdType="pubmed">35113777</ArticleId></ArticleIdList></Reference><Reference><Citation>Zheng C., Shao W., Chen X., Zhang B., Wang G., Zhang W. Real-world effectiveness of COVID-19 vaccines: A literature review and meta-analysis. Int. J. Infect. Dis. 2021;114:252&#x2013;260. doi: 10.1016/j.ijid.2021.11.009.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ijid.2021.11.009</ArticleId><ArticleId IdType="pmc">PMC8595975</ArticleId><ArticleId IdType="pubmed">34800687</ArticleId></ArticleIdList></Reference><Reference><Citation>Tofarides A.G., Christaki E., Milionis H., Nikolopoulos G.K. Effect of Vaccination against SARS-CoV-2 on Long COVID-19: A Narrative Review. Life. 2022;12:2057. doi: 10.3390/life12122057.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/life12122057</ArticleId><ArticleId IdType="pmc">PMC9785763</ArticleId><ArticleId IdType="pubmed">36556422</ArticleId></ArticleIdList></Reference><Reference><Citation>Regunath H., Goldstein N.M., Guntur V.P. Long COVID: Where Are We in 2023? Mo. Med. 2023;120:102&#x2013;105.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10121126</ArticleId><ArticleId IdType="pubmed">37091941</ArticleId></ArticleIdList></Reference><Reference><Citation>Alghamdi S., Alfares M., Alsulami R., Alghamdi A.F., Almalawi A.M., Alghamdi M.S., Hazazi H. Post-COVID-19 Syndrome: Incidence, Risk Factor, and the Most Common Persisting Symptoms. Cureus. 2022;14:e32058. doi: 10.7759/cureus.32058.</Citation><ArticleIdList><ArticleId IdType="doi">10.7759/cureus.32058</ArticleId><ArticleId IdType="pmc">PMC9802640</ArticleId><ArticleId IdType="pubmed">36600841</ArticleId></ArticleIdList></Reference><Reference><Citation>Lundberg-Morris L., Leach S., Xu Y., Martikainen J., Santosa A., Gissl&#xe9;n M., Li H., Nyberg F., Bygdell M. Covid-19 vaccine effectiveness against post-covid-19 condition among 589 722 individuals in Sweden: Population based cohort study. BMJ. 2023;383:e076990. doi: 10.1136/bmj-2023-076990.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj-2023-076990</ArticleId><ArticleId IdType="pmc">PMC10666099</ArticleId><ArticleId IdType="pubmed">37993131</ArticleId></ArticleIdList></Reference><Reference><Citation>Byambasuren O., Stehlik P., Clark J., Alcorn K., Glasziou P. Effect of covid-19 vaccination on long covid: Systematic review. BMJ Med. 2023;2:e000385. doi: 10.1136/bmjmed-2022-000385.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmjmed-2022-000385</ArticleId><ArticleId IdType="pmc">PMC9978692</ArticleId><ArticleId IdType="pubmed">36936268</ArticleId></ArticleIdList></Reference><Reference><Citation>Page M.J., McKenzie J.E., Bossuyt P.M., Boutron I., Hoffmann T.C., Mulrow C.D., Shamseer L., Tetzlaff J.M., Akl E.A., Brennan S.E., et al. The PRISMA 2020 statement: An updated guideline for reporting systematic reviews. Syst. Rev. 2021;10 doi: 10.1186/s13643-021-01626-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13643-021-01626-4</ArticleId><ArticleId IdType="pmc">PMC8008539</ArticleId><ArticleId IdType="pubmed">33781348</ArticleId></ArticleIdList></Reference><Reference><Citation>Schiavo J.H. PROSPERO: An International Register of Systematic Review Protocols. Med Ref. Serv. Q. 2019;38:171&#x2013;180. doi: 10.1080/02763869.2019.1588072.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/02763869.2019.1588072</ArticleId><ArticleId IdType="pubmed">31173570</ArticleId></ArticleIdList></Reference><Reference><Citation>Srikanth S., Boulos J.R., Dover T., Boccuto L., Dean D. Identification and diagnosis of long COVID-19: A scoping review. Prog. Biophys. Mol. Biol. 2023;182:1&#x2013;7. doi: 10.1016/j.pbiomolbio.2023.04.008.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.pbiomolbio.2023.04.008</ArticleId><ArticleId IdType="pmc">PMC10176974</ArticleId><ArticleId IdType="pubmed">37182545</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang C., Yang C., Zhao H., Zhao H., Esp&#xed;n E., Esp&#xed;n E., Tebbutt S.J., Tebbutt S.J. Association of SARS-CoV-2 infection and persistence with long COVID. Lancet Respir. Med. 2023;11:504&#x2013;506. doi: 10.1016/S2213-2600(23)00142-X.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2213-2600(23)00142-X</ArticleId><ArticleId IdType="pmc">PMC10171832</ArticleId><ArticleId IdType="pubmed">37178694</ArticleId></ArticleIdList></Reference><Reference><Citation>Al-Aly Z., Bowe B., Xie Y. Long COVID after breakthrough SARS-CoV-2 infection. Nat. Med. 2022;28:1461&#x2013;1467. doi: 10.1038/s41591-022-01840-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-022-01840-0</ArticleId><ArticleId IdType="pmc">PMC9307472</ArticleId><ArticleId IdType="pubmed">35614233</ArticleId></ArticleIdList></Reference><Reference><Citation>Antonelli M., Penfold R.S., Merino J., Sudre C.H., Molteni E., Berry S., Canas L.S., Graham M.S., Klaser K., Modat M., et al. Risk factors and disease profile of post-vaccination SARS-CoV-2 infection in UK users of the COVID Symptom Study app: A prospective, community-based, nested, case-control study. Lancet Infect. Dis. 2022;22:43&#x2013;55. doi: 10.1016/S1473-3099(21)00460-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1473-3099(21)00460-6</ArticleId><ArticleId IdType="pmc">PMC8409907</ArticleId><ArticleId IdType="pubmed">34480857</ArticleId></ArticleIdList></Reference><Reference><Citation>Ayoubkhani D., Bosworth M.L., King S., Pouwels K.B., Glickman M., Nafilyan V., Zaccardi F., Khunti K., Alwan N., Walker A.S. Risk of Long COVID in People Infected With Severe Acute Respiratory Syndrome Coronavirus 2 After 2 Doses of a Coronavirus Disease 2019 Vaccine: Community-Based, Matched Cohort Study. Open Forum Infect. Dis. 2022;9:ofac464. doi: 10.1093/ofid/ofac464.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/ofid/ofac464</ArticleId><ArticleId IdType="pmc">PMC9494414</ArticleId><ArticleId IdType="pubmed">36168555</ArticleId></ArticleIdList></Reference><Reference><Citation>Azzolini E., Levi R., Sarti R., Pozzi C., Mollura M., Mantovani A., Rescigno M. Association Between BNT162b2 Vaccination and Long COVID After Infections Not Requiring Hospitalization in Health Care Workers. JAMA. 2022;328:676&#x2013;678. doi: 10.1001/jama.2022.11691.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2022.11691</ArticleId><ArticleId IdType="pmc">PMC9250078</ArticleId><ArticleId IdType="pubmed">35796131</ArticleId></ArticleIdList></Reference><Reference><Citation>Brannock M.D., Chew R.F., Preiss A.J., Hadley E.C., Redfield S., McMurry J.A., Leese P.J., Girvin A.T., Crosskey M., Zhou A.G., et al. Long COVID risk and pre-COVID vaccination in an EHR-based cohort study from the RECOVER program. Nat. Commun. 2023;14:1&#x2013;12. doi: 10.1038/s41467-023-38388-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-023-38388-7</ArticleId><ArticleId IdType="pmc">PMC10201472</ArticleId><ArticleId IdType="pubmed">37217471</ArticleId></ArticleIdList></Reference><Reference><Citation>Ballouz T., Menges D., Kaufmann M., Amati R., Frei A., von Wyl V., Fehr J.S., Albanese E., Puhan M.A. Post COVID-19 condition after Wildtype, Delta, and Omicron SARS-CoV-2 infection and prior vaccination: Pooled analysis of two population-based cohorts. PLoS ONE. 2023;18:e0281429. doi: 10.1371/journal.pone.0281429.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0281429</ArticleId><ArticleId IdType="pmc">PMC9946205</ArticleId><ArticleId IdType="pubmed">36812215</ArticleId></ArticleIdList></Reference><Reference><Citation>Emecen A.N., Keskin S., Turunc O., Suner A.F., Siyve N., Sensoy E.B., Dinc F., Kilinc O., Oguz V.A., Bayrak S., et al. The presence of symptoms within 6 months after COVID-19: A single-center longitudinal study. Ir. J. Med Sci. 2022;192:741&#x2013;750. doi: 10.1007/s11845-022-03072-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11845-022-03072-0</ArticleId><ArticleId IdType="pmc">PMC9205653</ArticleId><ArticleId IdType="pubmed">35715663</ArticleId></ArticleIdList></Reference><Reference><Citation>Ioannou G.N., Baraff A., Fox A., Shahoumian T., Hickok A., O&#x2019;hare A.M., Bohnert A.S.B., Boyko E.J., Maciejewski M.L., Bowling C.B., et al. Rates and Factors Associated With Documentation of Diagnostic Codes for Long COVID in the National Veterans Affairs Health Care System. JAMA Netw. Open. 2022;5:e2224359. doi: 10.1001/jamanetworkopen.2022.24359.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamanetworkopen.2022.24359</ArticleId><ArticleId IdType="pmc">PMC9338411</ArticleId><ArticleId IdType="pubmed">35904783</ArticleId></ArticleIdList></Reference><Reference><Citation>Meza-Torres B., Delanerolle G., Okusi C., Mayor N., Anand S., Macartney J., Gatenby P., Glampson B., Chapman M., Curcin V., et al. Differences in Clinical Presentation With Long COVID After Community and Hospital Infection and Associations With All-Cause Mortality: English Sentinel Network Database Study. JMIR Public Health Surveill. 2022;8:e37668. doi: 10.2196/37668.</Citation><ArticleIdList><ArticleId IdType="doi">10.2196/37668</ArticleId><ArticleId IdType="pmc">PMC9384859</ArticleId><ArticleId IdType="pubmed">35605170</ArticleId></ArticleIdList></Reference><Reference><Citation>Mohr N.M., Plumb I.D., Harland K.K., Pilishvili T., Fleming-Dutra K., Krishnadasan A., Hoth K.F., Saydah S.H., Mankoff Z., Haran J.P., et al. Presence of symptoms 6 weeks after COVID-19 among vaccinated and unvaccinated US healthcare personnel: A prospective cohort study. BMJ Open. 2023;13:e063141. doi: 10.1136/bmjopen-2022-063141.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmjopen-2022-063141</ArticleId><ArticleId IdType="pmc">PMC9895915</ArticleId><ArticleId IdType="pubmed">36731936</ArticleId></ArticleIdList></Reference><Reference><Citation>Taquet M., Dercon Q., Harrison P.J. Six-month sequelae of post-vaccination SARS-CoV-2 infection: A retrospective cohort study of 10,024 breakthrough infections. Brain Behav. Immun. 2022;103:154&#x2013;162. doi: 10.1016/j.bbi.2022.04.013.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbi.2022.04.013</ArticleId><ArticleId IdType="pmc">PMC9013695</ArticleId><ArticleId IdType="pubmed">35447302</ArticleId></ArticleIdList></Reference><Reference><Citation>van der Maaden T., Mutubuki E.N., de Bruijn S., Leung K.Y., Knoop H., Slootweg J., Tulen A.D., Wong A., van Hoek A.J., Franz E., et al. Prevalence and Severity of Symptoms 3 Months After Infection With SARS-CoV-2 Compared to Test-Negative and Population Controls in the Netherlands. J. Infect. Dis. 2022;227:1059&#x2013;1067. doi: 10.1093/infdis/jiac474.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/infdis/jiac474</ArticleId><ArticleId IdType="pubmed">36477364</ArticleId></ArticleIdList></Reference><Reference><Citation>Zisis S.N., Durieux J.C., Mouchati C., Perez J., McComsey G. The Protective Effect of Coronavirus Disease 2019 (COVID-19) Vaccination on Postacute Sequelae of COVID-19: A Multicenter Study From a Large National Health Research Network. Open Forum Infect. Dis. 2022;9:ofac228. doi: 10.1093/ofid/ofac228.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/ofid/ofac228</ArticleId><ArticleId IdType="pmc">PMC9129153</ArticleId><ArticleId IdType="pubmed">35818362</ArticleId></ArticleIdList></Reference><Reference><Citation>Sudre C.H., Murray B., Varsavsky T., Graham M.S., Penfold R.S., Bowyer R.C., Pujol J.C., Klaser K., Antonelli M., Canas L.S., et al. Attributes and Predictors of Long COVID. Nat. Med. 2021;27:626&#x2013;631. doi: 10.1038/s41591-021-01292-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-021-01292-y</ArticleId><ArticleId IdType="pmc">PMC7611399</ArticleId><ArticleId IdType="pubmed">33692530</ArticleId></ArticleIdList></Reference><Reference><Citation>Asadi-Pooya A.A., Akbari A., Emami A., Lotfi M., Rostamihosseinkhani M., Nemati H., Barzegar Z., Kabiri M., Zeraatpisheh Z., Farjoud-Kouhanjani M., et al. Risk Factors Associated with Long COVID Syndrome: A Retrospective Study. Iran. J. Med. Sci. 2021;46:428&#x2013;436. doi: 10.30476/ijms.2021.92080.2326.</Citation><ArticleIdList><ArticleId IdType="doi">10.30476/ijms.2021.92080.2326</ArticleId><ArticleId IdType="pmc">PMC8611223</ArticleId><ArticleId IdType="pubmed">34840383</ArticleId></ArticleIdList></Reference><Reference><Citation>Chudzik M., Babicki M., Kapusta J., Ka&#x142;uzi&#x144;ska-Ko&#x142;at Z., Ko&#x142;at D., Jankowski P., Mastalerz-Migas, A. Long-COVID Clinical Features and Risk Factors: A Retrospective Analysis of Patients from the STOP-COVID Registry of the PoLoCOV Study. Viruses. 2022;14:1755. doi: 10.3390/v14081755.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/v14081755</ArticleId><ArticleId IdType="pmc">PMC9415629</ArticleId><ArticleId IdType="pubmed">36016376</ArticleId></ArticleIdList></Reference><Reference><Citation>Franco J.V.A., Garegnani L.I., Oltra G.V., Metzendorf M.-I., Trivisonno L.F., Sgarbossa N., Ducks D., Heldt K., Mumm R., Barnes B., et al. Long-Term Health Symptoms and Sequelae Following SARS-CoV-2 Infection: An Evidence Map. Int. J. Environ. Res. Public Health. 2022;19:9915. doi: 10.3390/ijerph19169915.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijerph19169915</ArticleId><ArticleId IdType="pmc">PMC9408764</ArticleId><ArticleId IdType="pubmed">36011562</ArticleId></ArticleIdList></Reference><Reference><Citation>Lam I.C.H., Wong C.K.H., Zhang R., Chui C.S.L., Lai F.T.T., Li X., Chan E.W.Y., Luo H., Zhang Q., Man K.K.C., et al. Long-term post-acute sequelae of COVID-19 infection: A retrospective, multi-database cohort study in Hong Kong and the UK. EClinicalMedicine. 2023;60:102000. doi: 10.1016/j.eclinm.2023.102000.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.eclinm.2023.102000</ArticleId><ArticleId IdType="pmc">PMC10173760</ArticleId><ArticleId IdType="pubmed">37197226</ArticleId></ArticleIdList></Reference><Reference><Citation>Mayor N., Meza-Torres B., Okusi C., Delanerolle G., Chapman M., Wang W., Anand S., Feher M., Macartney J., Byford R., et al. Developing a Long COVID Phenotype for Postacute COVID-19 in a National Primary Care Sentinel Cohort: Observational Retrospective Database Analysis. JMIR Public Health Surveill. 2022;8:e36989. doi: 10.2196/36989.</Citation><ArticleIdList><ArticleId IdType="doi">10.2196/36989</ArticleId><ArticleId IdType="pmc">PMC9374163</ArticleId><ArticleId IdType="pubmed">35861678</ArticleId></ArticleIdList></Reference><Reference><Citation>Watanabe A., So M., Iwagami M., Fukunaga K., Takagi H., Kabata H., Kuno T. One-year follow-up CT findings in COVID-19 patients: A systematic review and meta-analysis. Respirology. 2022;27:605&#x2013;616. doi: 10.1111/resp.14311.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/resp.14311</ArticleId><ArticleId IdType="pmc">PMC9350074</ArticleId><ArticleId IdType="pubmed">35694728</ArticleId></ArticleIdList></Reference><Reference><Citation>Polack F.P., Thomas S.J., Kitchin N., Absalon J., Gurtman A., Lockhart S., Perez J.L., P&#xe9;rez Marc G., Moreira E.D., Zerbini C., et al. Safety and efficacy of the BNT162b2 mRNA COVID-19 vaccine. N. Engl. J. Med. 2020;383:2603&#x2013;2615. doi: 10.1056/NEJMoa2034577.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMoa2034577</ArticleId><ArticleId IdType="pmc">PMC7745181</ArticleId><ArticleId IdType="pubmed">33301246</ArticleId></ArticleIdList></Reference><Reference><Citation>Sharif N., Alzahrani K.J., Ahmed S.N., Dey S.K. Efficacy, Immunogenicity and Safety of COVID-19 Vaccines: A Systematic Review and Meta-Analysis. Front. Immunol. 2021;12:714170. doi: 10.3389/fimmu.2021.714170.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2021.714170</ArticleId><ArticleId IdType="pmc">PMC8542872</ArticleId><ArticleId IdType="pubmed">34707602</ArticleId></ArticleIdList></Reference><Reference><Citation>Crook H., Raza S., Nowell J., Young M., Edison P. Long Covid&#x2014;Mechanisms, Risk Factors, and Management. BMJ. 2021;374:n1648. doi: 10.1136/bmj.n1648.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.n1648</ArticleId><ArticleId IdType="pubmed">34312178</ArticleId></ArticleIdList></Reference><Reference><Citation>Notarte K.I., de Oliveira M.H.S., Peligro P.J., Velasco J.V., Macaranas I., Ver A.T., Pangilinan F.C., Pastrana A., Goldrich N., Kavteladze D., et al. Age, Sex and Previous Comorbidities as Risk Factors Not Associated with SARS-CoV-2 Infection for Long COVID-19: A Systematic Review and Meta-Analysis. J. Clin. Med. 2022;11:7314. doi: 10.3390/jcm11247314.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/jcm11247314</ArticleId><ArticleId IdType="pmc">PMC9787827</ArticleId><ArticleId IdType="pubmed">36555931</ArticleId></ArticleIdList></Reference><Reference><Citation>Tran V.T., Perrodeau E., Saldanha J., Pane I., Ravaud P. Efficacy of covid-19 vaccination on the symptoms of patients with long covid: A target trial emulation using data from the compare e-Cohort in France. SSRN J. 2021 doi: 10.2139/ssrn.3932953.</Citation><ArticleIdList><ArticleId IdType="doi">10.2139/ssrn.3932953</ArticleId><ArticleId IdType="pmc">PMC9978748</ArticleId><ArticleId IdType="pubmed">36910458</ArticleId></ArticleIdList></Reference><Reference><Citation>Wynberg E., Han A.X., Boyd A., van Willigen H.D., Verveen A., Lebbink R., van der Straten K., Kootstra N., van Gils M.J., Russell C., et al. The effect of SARS-CoV-2 vaccination on post-acute sequelae of COVID-19 (PASC): A prospective cohort study. Vaccine. 2022;40:4424&#x2013;4431. doi: 10.1016/j.vaccine.2022.05.090.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.vaccine.2022.05.090</ArticleId><ArticleId IdType="pmc">PMC9170535</ArticleId><ArticleId IdType="pubmed">35725782</ArticleId></ArticleIdList></Reference><Reference><Citation>Chaichana U., Man K.K.C., Chen A., Wong I.C.K., George J., Wilson P., Wei L. Definition of Post&#x2013;COVID-19 Condition Among Published Research Studies. JAMA Netw. Open. 2023;6:e235856. doi: 10.1001/jamanetworkopen.2023.5856.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamanetworkopen.2023.5856</ArticleId><ArticleId IdType="pmc">PMC10077105</ArticleId><ArticleId IdType="pubmed">37017970</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang L., Li X., Gu X., Zhang H., Ren L., Guo L., Liu M., Wang Y., Cui D., Wang Y., et al. Health outcomes in people 2 years after su ospital ospitalizationlisation with COVID-19: A longi-tudinal cohort study. Lancet Respir Med. 2022;10:863&#x2013;876. doi: 10.1016/S2213-2600(22)00126-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2213-2600(22)00126-6</ArticleId><ArticleId IdType="pmc">PMC9094732</ArticleId><ArticleId IdType="pubmed">35568052</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen C., Haupert S.R., Zimmermann L., Shi X., Fritsche L.G., Mukherjee B. Global prevalence of post Coronavirus Disease 2019 (COVID-19) condition or long COVID: A meta-analysis and systematic review. J. Infect Dis. 2022;226:1593&#x2013;1607. doi: 10.1093/infdis/jiac136.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/infdis/jiac136</ArticleId><ArticleId IdType="pmc">PMC9047189</ArticleId><ArticleId IdType="pubmed">35429399</ArticleId></ArticleIdList></Reference><Reference><Citation>Zadeh F.H., Wilson D.R., Agrawal D.K. Long COVID: Complications, Underlying Mechanisms, and Treatment Strategies. Arch. Microbiol. Immunol. 2023;7:36&#x2013;61. doi: 10.26502/ami.93650103.</Citation><ArticleIdList><ArticleId IdType="doi">10.26502/ami.93650103</ArticleId><ArticleId IdType="pmc">PMC10310313</ArticleId><ArticleId IdType="pubmed">37388279</ArticleId></ArticleIdList></Reference><Reference><Citation>Thaweethai T., Jolley S.E., Karlson E.W., Levitan E.B., Levy B., McComsey G.A., McCorkell L., Nadkarni G.N., Parthasarathy S., Singh U., et al. Development of a Definition of Postacute Sequelae of SARS-CoV-2 Infection. JAMA. 2023;329:1934&#x2013;1946. doi: 10.1001/jama.2023.8823.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2023.8823</ArticleId><ArticleId IdType="pmc">PMC10214179</ArticleId><ArticleId IdType="pubmed">37278994</ArticleId></ArticleIdList></Reference><Reference><Citation>Finterer J., Scorza F. A retrospective analysis of clinically confirmed long post-COVID vaccination syndrome. J. Clin. Transl. Res. 2022;8:506&#x2013;508.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9706319</ArticleId><ArticleId IdType="pubmed">36452006</ArticleId></ArticleIdList></Reference><Reference><Citation>Dhuli K., Medori M.C., Micheletti C., Donato K., Fioretti F., Calzoni A., Praderio A., De Angelis M.G., Arabia G., Cristoni S., et al. Presence of viral spike protein and vaccinal spike protein in the blood serum of patients with long-COVID syndrome. Eur. Rev. Med. Pharmacol. Sci. 2023;27:13&#x2013;19. doi: 10.26355/eurrev_202312_34685.</Citation><ArticleIdList><ArticleId IdType="doi">10.26355/eurrev_202312_34685</ArticleId><ArticleId IdType="pubmed">38112944</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>